Evidence map›Paper›PMID 21442631›Full record

ArticleHepatology (Baltimore, Md.)2011

Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells.

Jörg Schrader, Timothy T Gordon-Walker, Rebecca L Aucott, Mariëlle van Deemter, Alexander Quaas, Shaun Walsh, Daniel Benten, Stuart J Forbes, Rebecca G Wells, John P Iredale

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 381 papers.

0numbers the graph read from it
0cells of the map it votes in
381citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

381 citing papers in PubMed, 727 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

321 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Jörg SchraderMedical Research Council (MRC) Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom; Department of Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Timothy T Gordon-Walker
Rebecca L Aucott
Mariëlle van Deemter
Alexander Quaas
Shaun Walsh
Daniel Benten
Stuart J Forbes
Rebecca G Wells
John P Iredale
Centre for Inflammation Research · GBMedical Research Council · GBUniversity Medical Center Hamburg-Eppendorf · DENinewells Hospital · GBUniversity of Edinburgh · GBUniversity of Pennsylvania · US

Funding

TGF-B Mediated Fibrosis in a Hepatic Stellate Cell ModelR01DK058123 · NIDDK · YALE UNIVERSITY · PI WELLS, REBECCA G · 2001 to 2016
$4.5M
Medical Research Council G0600033Medical Research Council G07000582Medical Research Council G0700582Medical Research Council G1000868NIDDK NIH HHS DK 058123NIDDK NIH HHS R01 DK058123
6 · The paper itself

Abstract

unlabelledThere is increasing evidence that the physical environment is a critical mediator of tumor behavior. Hepatocellular carcinoma (HCC) develops within an altered biomechanical environment, and increasing matrix stiffness is a strong predictor of HCC development. The aim of this study was to establish whether changes in matrix stiffness, which are characteristic of inflammation and fibrosis, regulate HCC cell proliferation and chemotherapeutic response. Using an in vitro system of "mechanically tunable" matrix-coated polyacrylamide gels, matrix stiffness was modeled across a pathophysiologically relevant range, corresponding to values encountered in normal and fibrotic livers. Increasing matrix stiffness was found to promote HCC cell proliferation. The proliferative index (assessed by Ki67 staining) of Huh7 and HepG2 cells was 2.7-fold and 12.2-fold higher, respectively, when the cells were cultured on stiff (12 kPa) versus soft (1 kPa) supports. This was associated with stiffness-dependent regulation of basal and hepatocyte growth factor-stimulated mitogenic signaling through extracellular signal-regulated kinase, protein kinase B (PKB/Akt), and signal transducer and activator of transcription 3. β1-Integrin and focal adhesion kinase were found to modulate stiffness-dependent HCC cell proliferation. Following treatment with cisplatin, we observed reduced apoptosis in HCC cells cultured on stiff versus soft (physiological) supports. Interestingly, however, surviving cells from soft supports had significantly higher clonogenic capacity than surviving cells from a stiff microenvironment. This was associated with enhanced expression of cancer stem cell markers, including clusters of differentiation 44 (CD44), CD133, c-kit, cysteine-X-cysteine receptor 4, octamer-4 (CXCR4), and NANOG.

conclusionIncreasing matrix stiffness promotes proliferation and chemotherapeutic resistance, whereas a soft environment induces reversible cellular dormancy and stem cell characteristics in HCC. This has implications for both the treatment of primary HCC and the prevention of tumor outgrowth from disseminated tumor cells. (HEPATOLOGY 2011;).

Indexed as

Carcinoma, HepatocellularCell Line, TumorCell ProliferationCisplatinExtracellular Signal-Regulated MAP KinasesHep G2 CellsHumansLiver NeoplasmsProto-Oncogene Proteins c-aktSTAT3 Transcription FactorCisplatinExtracellular Signal-Regulated MAP KinasesProto-Oncogene Proteins c-aktSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID21442631
PMCPMC3076070
OpenAlexW2097969181

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.